Hirotoshi Watanabe

17PUBLICATIONS
125CO-AUTHORS
PharmacogenomicsRespiratory diseasesCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 18, 2026
Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort.

Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki

|Feb 16, 2026
Changes in Demographics, Initial Treatment Strategies, and Clinical Outcomes of Severe Aortic Stenosis in the Pre- and Post-TAVR Era in Japan.

Yasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto

|Sep 24, 2025
Aspirin Versus Clopidogrel Beyond 1 Month After PCI in Patients With Oral Anticoagulation.

Masahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto

|Jun 04, 2025
P2Y12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials.

Daniele Giacoppo, Felice Gragnano, Hirotoshi Watanabe

|May 14, 2025
Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 Trial.

Tetsuya Ishikawa, Masahiro Natsuaki, Hirotoshi Watanabe

|Jan 25, 2025
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial.

Takenori Domei, Ko Yamamoto, Masahiro Natsuaki

Pageof 3

Frequent Collaborators

15 joint publications

Takeshi Kimura

11 joint publications

Takeshi Morimoto

10 joint publications

Yuki Obayashi

9 joint publications

Koh Ono